Literature DB >> 22310117

Is contrast exposure safe among the highest risk trauma patients?

Dennis Y Kim1, Leslie Kobayashi, Todd W Costantini, David Chang, Dale Fortlage, Terry Curry, Susan Wynn, Jay Doucet, Vishal Bansal, Raul Coimbra.   

Abstract

BACKGROUND: Despite improvements in the diagnosis and management of acute kidney injury (AKI), posttraumatic renal dysfunction continues to be associated with increased morbidity and mortality. Intravenous (IV) contrast is known to induce AKI in high-risk groups including the elderly and critically ill. We sought to determine whether IV contrast exposure among high-risk trauma patients resulted in renal dysfunction as defined by the Acute Kidney Injury Network criteria.
METHODS: We performed a 3-year retrospective analysis of all patients admitted to our Level I trauma center surgical intensive care unit for >48 hours. Patients with preexisting chronic renal dysfunction were excluded. We performed univariate and bivariate analyses to identify risk factors for AKI. Multivariable logistic regression analysis identified independent predictors for AKI. Subgroup analysis was undertaken among high-risk groups to include elderly patients (aged ≥65 years) with admission hypotension (systolic blood pressure <90 mm Hg) and an Injury Severity Score (ISS) ≥25.
RESULTS: Of the 6,317 patients, 571 (9.0%) patients met the inclusion criteria; 170 (29.8%) patients developed AKI. Age ≥65 years (odds ratio [OR] 2.26, 95% confidence interval [CI] = 1.06-4.80, p <0.034) and ISS ≥25 (OR 1.86, 95% CI = 1.12-3.07, p <0.015) were determined to be independent predictors of AKI. IV contrast was not identified to be a predictor of AKI. Upon subgroup analysis, IV contrast exposure was not a predictor of AKI among the elderly, hypotensive, or severely injured patients (ISS ≥25).
CONCLUSION: A complete trauma workup including studies requiring IV contrast exposure should be considered safe even among high-risk trauma patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22310117     DOI: 10.1097/TA.0b013e31823f36e0

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  7 in total

Review 1.  Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis.

Authors:  Stephan Ehrmann; Andrew Quartin; Brian P Hobbs; Vincent Robert-Edan; Cynthia Cely; Cynthia Bell; Genevieve Lyons; Tai Pham; Roland Schein; Yimin Geng; Karim Lakhal; Chaan S Ng
Journal:  Intensive Care Med       Date:  2017-02-14       Impact factor: 17.440

2.  Is measurement of renal function necessary for all trauma patients before iodinated contrast administration?

Authors:  Haddon Pantel; Kristian D Stensland; Jeffrey Hashim; Michael Rosenblatt
Journal:  Emerg Radiol       Date:  2017-05-11

3.  Acute kidney injury in trauma patients admitted to the ICU: a systematic review and meta-analysis.

Authors:  Signe Søvik; Marie Susanna Isachsen; Kine Marie Nordhuus; Christine Kooy Tveiten; Torsten Eken; Kjetil Sunde; Kjetil Gundro Brurberg; Sigrid Beitland
Journal:  Intensive Care Med       Date:  2019-02-06       Impact factor: 17.440

4.  Does intravenous contrast-enhanced computed tomography cause acute kidney injury? Protocol of a systematic review of the evidence.

Authors:  Jeanne Françoise Kayibanda; Swapnil Hiremath; Greg A Knoll; Dean Fergusson; Benjamin J W Chow; Wael Shabana; Ayub Akbari
Journal:  Syst Rev       Date:  2014-08-22

5.  Does angiography increase the risk of impairment in renal function during non-operative management of patients with blunt splenic injuries? A cross-sectional study in southern Taiwan.

Authors:  Ting-Min Hsieh; Tzu-Hsien Tsai; Chih-Che Lin; Ching-Hua Hsieh
Journal:  BMJ Open       Date:  2016-10-21       Impact factor: 2.692

Review 6.  Iodinated contrast medium: Is there a re(n)al problem? A clinical vignette-based review.

Authors:  Karim Lakhal; Stephan Ehrmann; Vincent Robert-Edan
Journal:  Crit Care       Date:  2020-11-10       Impact factor: 9.097

Review 7.  Contrast associated nephropathy after intravenous administration: what is the magnitude of the problem?

Authors:  Jean-Sebastien Rachoin; Yanika Wolfe; Sharad Patel; Elizabeth Cerceo
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.